-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$23.0040.33% Upside
NeoGenomics, Inc. Frequently Asked Questions
-
What analysts cover NeoGenomics, Inc.?
NeoGenomics, Inc. has been rated by research analysts at Needham, BTIG, Stephens, Piper Sandler, Morgan Stanley, Goldman Sachs in the past 90 days.